BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh N, Samant H, Hawxby A, Samaniego MD. Biomarkers of rejection in kidney transplantation. Curr Opin Organ Transplant 2019;24:103-10. [PMID: 30540576 DOI: 10.1097/MOT.0000000000000606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Halpern SE, Moris D, Shaw BI, Krischak MK, Olaso DG, Kesseli SJ, Ravindra K, McElroy LM, Barbas AS. The Systemic Immune-Inflammation Index Predicts Clinical Outcomes in Kidney Transplant Recipients. In Vivo 2020;34:3349-60. [PMID: 33144442 DOI: 10.21873/invivo.12173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Guzzi F, Cirillo L, Buti E, Becherucci F, Errichiello C, Roperto RM, Hunter JP, Romagnani P. Urinary Biomarkers for Diagnosis and Prediction of Acute Kidney Allograft Rejection: A Systematic Review. Int J Mol Sci 2020;21:E6889. [PMID: 32961825 DOI: 10.3390/ijms21186889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Alfaro R, Legaz I, Jimenez-Coll V, El Kaaoui El Band J, Martínez-Banaclocha H, Galián JA, Parrado A, Mrowiec A, Botella C, Moya-Quiles MR, Boix F, de la Peña-Moral J, Minguela A, Llorente S, Muro M. MicroRNA Expression Changes in Kidney Transplant: Diagnostic Efficacy of miR-150-5p as Potential Rejection Biomarker, Pilot Study. J Clin Med 2021;10:2748. [PMID: 34206682 DOI: 10.3390/jcm10132748] [Reference Citation Analysis]
4 Nguyen VD, Van Nguyen H, Seo JW, Lee SH, Seo TS. Prediction of acute rejection in kidney transplanted patients based on the point-of-care isothermal molecular diagnostics platform. Biosens Bioelectron 2021;199:113877. [PMID: 34920227 DOI: 10.1016/j.bios.2021.113877] [Reference Citation Analysis]
5 Butiu M, Obrisca B, Sibulesky L, Bakthavatsalam R, Smith KD, Gimferrer I, Warner P, Ismail G, Leca N. Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation. Transplantation Direct 2022;8:e1285. [DOI: 10.1097/txd.0000000000001285] [Reference Citation Analysis]